Novem Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.01M Sell
7,906
-1,165
-13% -$272K 0.2% 100
2026
Q1
$2.22M Buy
9,071
+377
+4% +$87.8K 0.25% 82
2025
Q4
$1.8M Buy
8,694
+117
+1% +$23.1K 0.21% 91
2025
Q3
$1.59M Buy
8,577
+135
+2% +$23.1K 0.19% 101
2025
Q2
$1.29M Sell
8,442
-938
-10% -$144K 0.16% 103
2025
Q1
$1.56M Buy
9,380
+1,111
+13% +$174K 0.22% 85
2024
Q4
$1.2M Buy
+8,269
New +$1.28M 0.17% 104

Other funds holding JNJ

Novem Group's JNJ Position: Q2 2026 in Review

Novem Group reduced its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, selling an estimated $272K and leaving 7,906 shares worth $2.01M. The position accounts for 0.2% of the portfolio, ranked #100.

Novem Group first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.22M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Novem Group held 7,906 shares of Johnson & Johnson worth $2.01M as of Q2 2026.
  • Novem Group sold 1,165 Johnson & Johnson shares in Q2 2026, an estimated $272K.
  • Johnson & Johnson made up 0.2% of Novem Group's portfolio in Q2 2026, its #100 holding.
  • Novem Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Johnson & Johnson position peaked at $2.22M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.